Skip to main content
OpenTrials
Completed

NCT Number: NCT00567983

Topical Cyclosporine and Disease Progression

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Disease Progression Disease Attributes Disease Severity OSDI Pathologic Processes Pathological Conditions, Signs and Symptoms Schirmers Staining

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Lakeside Eye Clinic

Chicago, Illinois, 60641, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Mild to Moderate dry eye symptoms

Exclusion criteria

  • Current use of Restasis

Treatment and study plan

Restasis

Drug

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Endura

Drug

Restasis- (in the eye) Instill one drop twice daily Endura- (in the eye) Instill one drop twice daily

Primary outcomes

  1. Disease Severity

    Time frame: 1 yr

Secondary outcomes

  1. Staining

    Time frame: 1 yr

Sponsors and collaborators

Lead sponsor

Innovative Medical

Industry

Registry information

Important dates

Study start
2007
Primary completion
2008
Study completion
2008
First posted
Dec 5, 2007
Registry last updated
Sep 25, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.